ANTINEOPLASTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
BICALUTAMIDE: products 1 to 9 of 9.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Bicalutamide 50mg TabDIN 02296063 | General benefit | $1.2690per source unit | Requirements & sourcesBuild cost plan |
| Bicalutamide 50mg TabDIN 02519178 | General benefit | $1.2690per source unit | Requirements & sourcesBuild cost plan |
| Bicalutamide Tablets 50mg TabDIN 02325985 | General benefit | $1.2690per source unit | Requirements & sourcesBuild cost plan |
| Casodex 50mg TabDIN 02184478 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Co Bicalutamide 50mg TabDIN 02274337 | General benefit | $1.2690per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Bicalutamide 50mg TabDIN 02357216 | General benefit | $1.2690per source unit | Requirements & sourcesBuild cost plan |
| PMS-Bicalutamide 50mg TabDIN 02275589 | General benefit | $1.2690per source unit | Requirements & sourcesBuild cost plan |
| Ran-Bicalutamide 50mg TabDIN 02371324 | General benefit | $1.2690per source unit | Requirements & sourcesBuild cost plan |
| Teva-Bicalutamide 50mg TabDIN 02270226 | General benefit | $1.2690per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
10:00 ANTINEOPLASTIC AGENTS.